The vitamin E status among glucose-6 phosphate dehydrogenase deficient patients and effectiveness of oral vitamin E

The effect of oral vitamin E therapy (800 IU/day) on correcting haematologic variables and on raising the plasma vitamin E level among glucose-6 phosphate dehydrogenase deficient subjects with history of hemolysis was studied. After 16 week period there was a positive response to vitamin E administration presented by sustained improvement in blood hemoglobin and plasma vitamin E concentrations. In the meanwhile, the vitamin E supplementation led to reduced reticulocytosis and control % hemolysis.